Salud financiera de hoja de balance de Alkermes
Salud financiera controles de criterios 6/6
Alkermes tiene un patrimonio de accionistas total de $1.3B y una deuda total de $288.8M, lo que sitúa su ratio deuda-patrimonio en 22.4%. Sus activos y pasivos totales son $2.2B y $863.2M respectivamente. El BAIT de Alkermes es de $318.6M, por lo que su ratio de cobertura de intereses es de -18.9. Tiene efectivo e inversiones a corto plazo que ascienden a $908.9M.
Información clave
22.4%
Ratio deuda-patrimonio
US$288.82m
Deuda
| Ratio de cobertura de intereses | -18.9x |
| Efectivo | US$908.86m |
| Patrimonio | US$1.29b |
| Total pasivo | US$863.19m |
| Activos totales | US$2.16b |
Actualizaciones recientes sobre salud financiera
Is Alkermes (NASDAQ:ALKS) A Risky Investment?
Sep 17
Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?
Apr 08Is Alkermes (NASDAQ:ALKS) Using Too Much Debt?
Nov 01Is Alkermes (NASDAQ:ALKS) Using Debt Sensibly?
Jul 15Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?
Mar 20Health Check: How Prudently Does Alkermes (NASDAQ:ALKS) Use Debt?
Aug 29Recent updates
Alkermes plc's (NASDAQ:ALKS) Low P/E No Reason For Excitement
Oct 14Is Alkermes (NASDAQ:ALKS) A Risky Investment?
Sep 17Alkermes: Fairly Valued After Post-Earnings Bump
Jul 28Does Alkermes (NASDAQ:ALKS) Deserve A Spot On Your Watchlist?
Jul 26Alkermes plc's (NASDAQ:ALKS) Business And Shares Still Trailing The Industry
Jul 04The Bottom Fishing Club: Alkermes Has Great Value And Safety
May 17Alkermes' (NASDAQ:ALKS) Solid Profits Have Weak Fundamentals
May 08Alkermes: Waking Up Narcolepsy Treatment With Promising Trial Data
Apr 09Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?
Apr 08Alkermes: Slimmed-Down Pharma Not A Compelling Growth Story Yet
Jan 26Is Alkermes (NASDAQ:ALKS) Using Too Much Debt?
Nov 01Alkermes' (NASDAQ:ALKS) Earnings May Just Be The Starting Point
Nov 01Is Alkermes (NASDAQ:ALKS) Using Debt Sensibly?
Jul 15There Is A Reason Alkermes plc's (NASDAQ:ALKS) Price Is Undemanding
Jun 07Is Alkermes plc (NASDAQ:ALKS) Trading At A 44% Discount?
Apr 10Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?
Mar 20Alkermes upgraded to neutral at BofA on improved risk/reward outlook
Oct 14Alkermes holder Sarissa Capital says it may look to increase its stake
Oct 07Alkermes: Nothing Stands Out As Interesting
Sep 26Health Check: How Prudently Does Alkermes (NASDAQ:ALKS) Use Debt?
Aug 29Alkermes initiated at neutral at Piper Sandler as company in transition
Aug 16Alkermes Q2 2022 Earnings Preview
Jul 26Is There An Opportunity With Alkermes plc's (NASDAQ:ALKS) 44% Undervaluation?
Jun 27Alkermes (NASDAQ:ALKS) Has Debt But No Earnings; Should You Worry?
May 16Alkermes: Turning The Tides Towards Profitability
Apr 16Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($1.6B) de ALKS superan a sus pasivos a corto plazo ($453.7M).
Pasivo a largo plazo: Los activos a corto plazo de ALKS ($1.6B) superan a sus pasivos a largo plazo ($409.5M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: ALKS tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de ALKS ha pasado de 26% a 22.4% en los últimos 5 años.
Cobertura de la deuda: La deuda de ALKS está bien cubierta por el flujo de caja operativo (123.2%).
Cobertura de intereses: ALKS gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.